Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Eva MM Strijbis"'
Autor:
Eva MM Strijbis, Pavle Repovic, Jop Mostert, James D Bowen, Bernard MJ Uitdehaag, Gary Cutter, Marcus W Koch
Publikováno v:
Multiple Sclerosis Journal, 28(10), 1606-1619. SAGE Publications Ltd
Strijbis, E M M, Repovic, P, Mostert, J, Bowen, J D, Uitdehaag, B M J, Cutter, G & Koch, M W 2022, ' The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials ', Multiple Sclerosis Journal, vol. 28, no. 10, pp. 1606-1619 . https://doi.org/10.1177/13524585221105465
Strijbis, E M M, Repovic, P, Mostert, J, Bowen, J D, Uitdehaag, B M J, Cutter, G & Koch, M W 2022, ' The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials ', Multiple Sclerosis Journal, vol. 28, no. 10, pp. 1606-1619 . https://doi.org/10.1177/13524585221105465
Background: Patient-reported outcome measures (PROMs) are often used in clinical research, but little is known about their performance as longitudinal outcomes. Methods: We used data from ASCEND, a large SPMS trial ( n = 889), to investigate changes
Autor:
Shira Simon, Ilse M Nauta, Arjan Hillebrand, Menno M Schoonheim, Bernard MJ Uitdehaag, Maureen van Dam, Hanneke E Hulst, Martin Klein, Cornelis J Stam, Brigit A de Jong, Eva MM Strijbis
Publikováno v:
Multiple Sclerosis Journal. SAGE Publications Ltd
Simon, S, Nauta, I M, Hillebrand, A, Schoonheim, M M, Uitdehaag, B M J, van Dam, M, Hulst, H E, Klein, M, Stam, C J, de Jong, B A & Strijbis, E M M 2023, ' Neurophysiological MEG markers of cognitive impairment and performance validity in multiple sclerosis ', Multiple Sclerosis Journal . https://doi.org/10.1177/13524585231159817
Simon, S, Nauta, I M, Hillebrand, A, Schoonheim, M M, Uitdehaag, B M J, van Dam, M, Hulst, H E, Klein, M, Stam, C J, de Jong, B A & Strijbis, E M M 2023, ' Neurophysiological MEG markers of cognitive impairment and performance validity in multiple sclerosis ', Multiple Sclerosis Journal . https://doi.org/10.1177/13524585231159817
Background: Suboptimal performance during neuropsychological testing frequently occurs in multiple sclerosis (MS), leading to unreliable cognitive outcomes. Neurophysiological alterations correlate with MS-related cognitive impairment, but studies ha
Autor:
Alyssa A Toorop, Theo Rispens, Eva MM Strijbis, Bob W van Oosten, Brigit A de Jong, Bernard MJ Uitdehaag, Joep Killestein, Zoé LE van Kempen
Publikováno v:
Multiple Sclerosis Journal. SAGE Publications Ltd
Multiple Sclerosis (Houndmills, Basingstoke, England)
Toorop, A A, Rispens, T, Strijbis, E M M, van Oosten, B W, de Jong, B A, Uitdehaag, B M J, Killestein, J & van Kempen, Z L E 2021, ' Natalizumab concentrations during pregnancy in three patients with multiple sclerosis ', Multiple Sclerosis Journal . https://doi.org/10.1177/13524585211052168
Multiple Sclerosis (Houndmills, Basingstoke, England)
Toorop, A A, Rispens, T, Strijbis, E M M, van Oosten, B W, de Jong, B A, Uitdehaag, B M J, Killestein, J & van Kempen, Z L E 2021, ' Natalizumab concentrations during pregnancy in three patients with multiple sclerosis ', Multiple Sclerosis Journal . https://doi.org/10.1177/13524585211052168
In women with very active multiple sclerosis (MS), natalizumab can be continued during pregnancy to prevent rebound disease activity. Our aim was to evaluate changes in serum natalizumab trough concentrations during pregnancy. Blood samples of 3 pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9910ddf91621ae7cc01668a003aba1d5
https://research.vumc.nl/en/publications/fa1b4359-5857-4374-a72c-f2045a280df4
https://research.vumc.nl/en/publications/fa1b4359-5857-4374-a72c-f2045a280df4